Original article| Volume 40, ISSUE 7, P552-557, August 2018

Early risk factors for mortality in children with seizure and/or impaired consciousness accompanied by fever without known etiology



      Children who present with seizure and/or impaired consciousness accompanied by fever without known etiology (SICF) may be diagnosed with either acute encephalopathy (AE) or febrile seizure (FS). Although approximately 5% of AE cases are fatal, it is difficult to identify fatal cases among children with SICF, which are often critical by the time of diagnosis. Thus, early prediction of outcomes for children with SICF, prior to diagnosis, may help to reduce mortality associated with AE. The aim of the present study was to identify clinical and laboratory risk factors for mortality acquired within 6 h of onset among children with SICF.


      We retrospectively reviewed the medical records of children who had been admitted to Kobe Children’s Hospital (Kobe, Japan) with SICF between October 2002 and September 2015. We compared clinical and laboratory characteristics acquired within 6 h of onset and outcomes between survivors and non-survivors using univariate and multivariate analyses.


      The survivor and non-survivor groups included 659 and nine patients, respectively. All patients in the non-survivor group received a final diagnosis of AE. Univariate analysis revealed significant differences between the groups with regard to seizure duration and the following laboratory parameters: aspartate transaminase (AST), alanine aminotransferase, lactate dehydrogenase, sodium, and lactate. The multivariate analysis identified AST as a significant independent factor associated with mortality.


      Elevation of AST within 6 h of onset is independently correlated with mortality in children with SICF. Our result may elucidate earlier intervention for patients with high risk of mortality.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Swaiman’s Pediatric neurology. fifth ed. 2011: 90-91
        • Hoshino A.
        • Saitoh M.
        • Oka A.
        • Okumura A.
        • Kubota M.
        • Saito Y.
        • et al.
        Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.
        Brain Dev. 2012; 34: 337-343
        • Bacon C.J.
        • Hall S.M.
        Haemorrhagic shock encephalopathy syndrome in the British Isles.
        Arch Dis Child. 1992; 67: 985-993
        • Rinka H.
        • Yoshida T.
        • Tsuruwa M.
        • Fuke A.
        • Yoshimoto A.
        • Kan M.
        • et al.
        Hemorrhagic shock and encephalopathy syndrome–the markers for an early HSES diagnosis.
        BMC Pediatr. 2008; 8: 43
        • Nagase H.
        • Nakagawa T.
        • Aoki K.
        • Fujita K.
        • Saji Y.
        • Maruyama A.
        • et al.
        Therapeutic indicators of acute encephalopathy in patients with complex febrile seizures.
        Pediatr Int. 2013; 55: 310-314
        • Tada H.
        • Takanashi J.
        • Okuno H.
        • Kubota M.
        • Yamagata T.
        • Kawano G.
        • et al.
        Predictive score for early diagnosis of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD).
        J Neurol Sci. 2015; 358: 62-65
        • Yokochi T.
        • Takeuchi T.
        • Mukai J.
        • Akita Y.
        • Nagai K.
        • Obu K.
        • et al.
        Prediction of acute encephalopathy with biphasic seizures and late reduced diffusion in patients with febrile status epilepticus.
        Brain Dev. 2016; 38: 217-224
        • Sasaki K.
        • Nagase H.
        • Maruyama A.
        • Fujita K.
        • Nishiyama M.
        • Tanaka T.
        • et al.
        Clinical prediction rule for neurological sequelae due to acute encephalopathy: a medical community-based validation study in Harima, Japan.
        BMJ Open. 2017; 7: e016675
      2. Mizuguchi M, Ichiyama T, Imataka G, Okumura A, Gotoh T, (ed.), Guideline for acute encephalopathy (in Japanese). Tokyo: Shindan-To-Chiryosha; 2016.

        • Fiser D.H.
        Assessing the outcome of pediatric intensive care.
        J Pediatr. 1992; 121: 68-74
        • Takanashi J.
        • Tada H.
        • Terada H.
        • Barkovich A.J.
        Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion.
        Am J Neuroradiol. 2009; 30: 132-135
        • Mizuguchi M.
        • Abe J.
        • Mikkaichi K.
        • Noma S.
        • Yoshida K.
        • Yamanaka T.
        • et al.
        Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions.
        J Neurol Neurosurg Psychiatry. 1995; 58: 555-561
        • Sakuma H.
        Acute encephalitis with refractory, repetitive partial seizures.
        Brain Dev. 2009; 31: 510-514
        • Hurwitz E.S.
        • Nelson D.B.
        • Davis C.
        • Morens D.
        • Schonberger L.B.
        National surveillance for Reye syndrome: a five-year review.
        Pediatrics. 1982; 70: 895-900
        • Kanda Y.
        Investigation of the freely available easy-to-use software 'EZR' for medical statistics.
        Bone Marrow Transplant. 2013; 48: 452-458
        • Morita H.
        • Hosoya M.
        • Kato A.
        • Kawasaki Y.
        • Suzuki H.
        Laboratory characteristics of acute encephalopathy with multiple organ dysfunctions.
        Brain Dev. 2005; 27: 477-482
        • Mizuguchi M.
        • Yamanouchi H.
        • Ichiyama T.
        • Shiomi M.
        Acute encephalopathy associated with influenza and other viral infections.
        Acta Neurol Scand. 2007; 115: 45-56
        • Kido H.
        Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options.
        Proc Jpn Acad Ser B Phys Biol Sci. 2015; 91: 351-368
        • Chida J.
        • Ono R.
        • Yamane K.
        • Hiyoshi M.
        • Nishimura M.
        • Onodera M.
        • et al.
        Blood lactate/ATP ratio, as an alarm index and real-time biomarker in critical illness.
        PLoS One. 2013; 8: e60561
        • Eriksson K.J.
        • Koivikko M.J.
        Status epilepticus in children: aetiology, treatment, and outcome.
        Dev Med Child Neurol. 1997; 39: 652-658
        • Towne A.R.
        • Pellock J.M.
        • Ko D.
        • DeLorenzo R.J.
        Determinants of mortality in status epilepticus.
        Epilepsia. 1994; 35: 27-34
        • Orringer C.E.
        • Eustace J.C.
        • Wunsch C.D.
        • Gardner L.B.
        Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia.
        N Engl J Med. 1977; 297: 796-799
        • Logroscino G.
        • Hesdorffer D.C.
        • Cascino G.
        • Annegers J.F.
        • Hauser W.A.
        Short-term mortality after a first episode of status epilepticus.
        Epilepsia. 1997; 38: 1344-1349
        • Raspall-Chaure M.
        • Chin R.F.
        • Neville B.G.
        • Scott R.C.
        Outcome of paediatric convulsive status epilepticus: a systematic review.
        Lancet Neurol. 2006; 5: 769-779
        • Adrogue H.J.
        • Madias N.E.
        N Engl J Med. 2000; 342: 1581-1589
        • Gerigk M.
        • Gnehm H.E.
        • Rascher W.
        Arginine vasopressin and renin in acutely ill children: implication for fluid therapy.
        Acta Paediatr. 1996; 85: 550-553
        • Sharples P.M.
        • Seckl J.R.
        • Human D.
        • Lightman S.L.
        • Dunger D.B.
        Plasma and cerebrospinal fluid arginine vasopressin in patients with and without fever.
        Arch Dis Child. 1992; 67: 998-1002
        • Kruk B.
        • Sadowski J.
        Antidiuretic action of intravenous and intracerebral pyrogen in conscious rabbits.
        J Physiol. 1978; 282: 429-435
        • Cooper K.E.
        • Kasting N.W.
        • Lederis K.
        • Veale W.L.
        Evidence supporting a role for endogenous vasopressin in natural suppression of fever in the sheep.
        J Physiol. 1979; 295: 33-45